Search
/our-company/strategy
ALK strategy 2028, Boy on scooter v9.jpg, Focus
,
.h2-strategy-heading {
margin: 0;
font-weight: 600;
font-family: Vertigo;
font-size: 35px;
color: #0a2455;
}
We are the pioneers of a
,
Allergy is the most common chronic disease globally and it has profound impact on people’s lives. More than 500 million people worldwide live with res
,
.container {
display: flex;
}
.text-column,
.image-column {
flex: 1;
}
.image-column img {
width: 100%;
height: auto;
}
.image-colu
,
.primary-image-one {
aspect-ratio: 1 / 1;
width: 75% !important;
height: auto !important;
}
.secondary-image-one {
,
.primary-image-two {
aspect-ratio: 1 / 1;
width: 85% !important;
height: auto !important;
margin-left: auto;
}
.secondary-image-two {
,
.primary-image-three{
aspect-ratio: 1 / 1;
width: 70% !important;
height: auto !important;
margin-left: auto;
margin-top: auto;
}
.s
,
.primary-image-four{
aspect-ratio: 1 / 1;
width: 70% !important;
height: auto !important;
margin-left: auto;
margin-top: auto;
}
.se
,
.container-text-image {
display: grid;
grid-template-columns: 1fr 1.1fr;
column-gap: 6%;
}
.container-heading-subheading {
grid-column:
/code-conduct
Living our purpose and our cultural beliefs
,
ALK_CodeOfConduct_UK_WEB_new.pdf, ALK's Code of Conduct, Download, download
/affiliate-list
ALK affiliates, DenmarkALK-Abello A/S (parent)CVR no. 63 71 79 16Bøge Alle 6-8DK-2970 HørsholmDenmarkT: (+45) 4574 7576 ALK-Abello Nordic A/SCVR no. 31 50 12 96Bøge A
/our-company/newsroom/stories
Allergy solutions for life, ALK stories, stories_background_image.jpeg
,
stories_picture_promo_9.jpeg, ALK announces allergy diagnostic partnership with Rellergen in China, Read more here, stories_picture_promo_10.jpeg, "Get your head out of the spreadsheets and look at the people", Read more here, stories_picture_pr…,
stories_picture_promo_12.jpeg, Henning Løwenstein Research Award 2021, Read more here, stories_picture_promo_13.jpeg, ALK Netherlands hosts beehives, Read more here
,
alk_profilbrochure_oktober17.pdf, ALK - the allergy company, Allergy solutions for life, download
,
Allergy & asthma, stories_picture_promo_14.jpeg, Facts about pollen allergy, Read more here, stories_picture_promo_15.jpeg, Fight pollen allergy before it fights you, Read more here, stories_picture_promo_16.jpeg, Getting your child through the pollen…,
stories_picture_promo_17.jpeg, The real monsters are closer than you think, Read more here, stories_picture_promo_18.jpeg, Feeling a bit ill all year around?, Read more here, stories_picture_promo_19.jpeg, House dust mite allergy might be stealing your sl…,
stories_picture_promo_20.jpeg, National Penicillin Allergy Day, Read more here, stories_picture_promo_21.jpeg, Kornel Golebski wins allergy research award, Read more here
/data-proctection-officer
Data Protection Officer (DPO), If you have any questions regarding your data protection rights or requests for access to your data etc., you are always welcome to contact our Data P
/our-company/global-presence
Global presence, Allergy solutions for life, global_presence_background_image.jpeg
,
Addressing a global problem, Left, It is estimated that 10-20% of allergic rhinitis sufferers have a condition which is not well controlled despite the use of symptom-relieving medicati, global_presence_text_image.jpeg, Read more about our solutions
/our-company/history
ALK milestones, A history of firsts, history_background_image.jpeg
,
Since 1923, when pharmacist Peter Barfod and physician Kaj Baagøe documented the first pharmaceutically manufactured allergy preparation, ALK has led
,
Explore the history of ALK, ALK's foundation, history_timeline_1.jpeg, year, Dedicated facilities, history_timeline_2.jpeg, year, A new industry standard, history_timeline_3.jpeg, year, A world first, history_timeline_4.jpeg, year, New owner, history…,
Decades of pushing boundaries and raising standards have placed us at the forefront of our industry, and in recent years, we have invested heavily in
,
From laboratory to global concern, The book about ALK was written in connection with the company's 100 year anniversary in 2023.The purpose of the book is to give the company's surround, Left, From goose feathers to Grazax - The history of ALK
/our-science/pipeline
Pipeline, Tablets for the big five, pipeline_background_image.jpeg
,
Back then, research was small-scale, the evidence for allergy immunotherapy was limited and medical science was still in its infancy.Over the decades,
,
Left, Completing the tablet portfolioMost recently, we have developed a range of SLIT-tablets covering five of the most common global allergies – house dust, alk_tablet_pipeline.jpeg, Read more about financials
/our-company/owners
Owners, Our owners’ contribution to society, owners_background_image.jpeg
,
A stable ownership structure, The Lundbeck Foundation, one of Denmark’s largest enterprise foundations, is the controlling shareholder of ALK, holding 67% of the votes and 40% of t
,
Overview of the Lundbeck Foundation, ALK’s controlling shareholderThe Lundbeck Foundation is the largest and controlling shareholder of ALK, owning 40% of the capital and controlling 67% , Left, Read more about the Lundbeck Foundation
/our-solutions/consumer-healthcare
Consumer healthcare, Making life with allergy simple, consumer_healthcare_background_image.jpeg
,
Allergy is the most widespread chronic disease in the world and, while ALK is an established expert in the field, just 1% of people with allergy curre
,
Left, Digital eco-systemDespite these frustrations, research shows that people with allergies are highly engaged in managing their condition, and take daily, klara (1).jpg, Read more about klarify, Read more about the allergy app